Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Directorate Change

12 Oct 2020 07:00

RNS Number : 7047B
Wilmington PLC
12 October 2020
 

12 October 2020

Wilmington plc

("Wilmington" or the "Group")

Board Change

 

Wilmington plc, the provider of information, education and networking services in Risk & Compliance, Healthcare and Professional knowledge areas, is pleased to announce the appointment to the Board from 5 November 2020 of Guy Millward as Chief Financial Officer Designate.

 

Richard Amos, the current Chief Financial Officer, informed the Board of his desire to move away from a full-time executive role once a suitable successor had been found. He will resign from the Board and leave the Company on 10 December 2020 at which time Guy Millward will formally become Chief Financial Officer and Company Secretary. Guy will be joining Wilmington on 5 November and will be working closely with Richard and the rest of the senior executive team to ensure a smooth transition before Richard's departure in December.

 

Guy brings a wealth of experience to Wilmington following nearly twenty years as a listed company Finance Director and CFO working predominantly with technology companies including Kewill plc, Advanced Computer Software Group plc, Imagination Technologies Group plc and most recently Quixant plc. He qualified as a Chartered Accountant with EY. He is currently a Non-Executive Director and Chairman of the Audit Committee of Eckoh plc.

 

The Board looks forward to updating shareholders on current trading at the time of its Annual General Meeting on 4 November 2020.

 

Martin Morgan, Chairman, commented:

 

"We are very grateful to Richard for his contribution to Wilmington over the last three years and, in particular, for the leadership he has shown in navigating the Group through the challenges presented by the current global pandemic. We wish him well in his future career.

 

I am delighted to welcome Guy to Wilmington. His proven track record of success as a CFO of public companies and the experience that he brings from the technology sector will be hugely valuable to the Group as we continue to grow the business and execute on our digitisation strategy."

 

Mark Milner, Chief Executive Officer, commented:

 

"I would like to add my own thanks to Richard for his commitment to Wilmington and for his support in my first year as CEO, including his active role in the appointment of his successor. I wish him the very best as he embarks on his next ventures.

 

I am very much looking forward to having Guy as part of my executive team as we continue with the delivery of our strategy of focussing on generating organic growth in all parts of Wilmington."

 

 

Additional disclosures required under Listing Rule 9.6.13 R (1) to (6) in relation to the appointment of Guy Millward.

 

Current directorships

Eckoh plc

 

Past directorships (within the past five years)

Quixant plc

Imagination Technologies Group plc

 

 

 

 

For further information, please contact:

 

Wilmington plc 020 7490 0049

 

Mark Milner, Chief Executive Officer

Richard Amos, Chief Financial Officer

 

FTI Consulting 020 3727 1000

Charles Palmer / Dwight Burden / Emma Hall

 

 

Notes to Editors 

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington plc is listed on the main market of the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKKCBQKBDBBKK
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.